Post-authorization changes in the safety and efficacy assessment, recommended indications and drug quality profile of adalimumab: A chronological overview
JavaScript is disabled for your browser. Some features of this site may not work without it.
Post-authorization changes in the safety and efficacy assessment, recommended indications and drug quality profile of adalimumab: A chronological overview
Iványi, G; Zelkó, Romána
Folyóiratcikk
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
vol.:55,
issue.:2,
p.:133-137.